During early drug developments, meeting delivery deadlines takes higher priority than process optimization. As a drug candidate moves forward in developmental phases, production at increasing quantity demands for optimized processes meeting multi-dimensional constraints, such as cost, safety, environmental, regulatory, etc..
• Optimize via Quality by Design (QbD)
The best approach to quality assurance in pharmaceutical manufacturing is to design and control processes based on
fundamental understanding of underlining sciences and technologies. We optimize crystallization processes based on
QbD principles and strive for high quality standards.
• Enhance Processing Efficiency
Processing efficiency is critical to pharmaceutical manufactures, and a focus of our crystallization process development.
We optimize for high processing efficiency considering various aspects, such as time, volume, material, wastes, etc..